Goldman Sachs Group Inc. Grows Position in Waystar Holding Corp. $WAY

Goldman Sachs Group Inc. increased its holdings in Waystar Holding Corp. (NASDAQ:WAY) by 33.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,827,474 shares of the company’s stock after acquiring an additional 705,429 shares during the quarter. Goldman Sachs Group Inc. owned approximately 1.48% of Waystar worth $92,600,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. ANTIPODES PARTNERS Ltd lifted its stake in Waystar by 120.1% in the third quarter. ANTIPODES PARTNERS Ltd now owns 823 shares of the company’s stock worth $31,000 after acquiring an additional 449 shares during the period. Danske Bank A S purchased a new stake in Waystar in the fourth quarter worth about $52,000. EverSource Wealth Advisors LLC lifted its stake in Waystar by 3,219.0% in the second quarter. EverSource Wealth Advisors LLC now owns 1,394 shares of the company’s stock worth $57,000 after acquiring an additional 1,352 shares during the period. GAMMA Investing LLC lifted its stake in Waystar by 613.4% in the fourth quarter. GAMMA Investing LLC now owns 1,762 shares of the company’s stock worth $58,000 after acquiring an additional 1,515 shares during the period. Finally, 1620 Investment Advisors Inc. purchased a new stake in shares of Waystar during the fourth quarter valued at about $77,000.

Wall Street Analyst Weigh In

Several analysts have commented on WAY shares. Bank of America decreased their price target on shares of Waystar from $45.00 to $38.00 and set a “buy” rating for the company in a research report on Friday, April 10th. BMO Capital Markets decreased their price target on shares of Waystar from $47.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday, February 18th. Jefferies Financial Group reissued a “buy” rating and set a $41.00 price target on shares of Waystar in a research report on Wednesday, February 18th. TD Cowen reissued a “buy” rating on shares of Waystar in a research report on Wednesday, February 18th. Finally, Citigroup decreased their price target on shares of Waystar from $35.00 to $30.00 and set a “buy” rating for the company in a research report on Tuesday, May 5th. Three research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $35.62.

Waystar Stock Performance

WAY stock opened at $19.17 on Wednesday. The firm has a market cap of $3.68 billion, a price-to-earnings ratio of 28.61, a PEG ratio of 0.75 and a beta of 0.10. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.76 and a current ratio of 1.76. The firm has a 50-day simple moving average of $21.78 and a two-hundred day simple moving average of $26.50. Waystar Holding Corp. has a one year low of $17.89 and a one year high of $41.47.

Waystar (NASDAQ:WAY) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.39 by $0.03. The firm had revenue of $313.87 million during the quarter, compared to analyst estimates of $311.74 million. Waystar had a net margin of 10.90% and a return on equity of 6.99%. Waystar’s revenue was up 22.4% on a year-over-year basis. During the same period last year, the firm posted $0.32 EPS. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. On average, equities analysts forecast that Waystar Holding Corp. will post 1.46 EPS for the current fiscal year.

About Waystar

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.